Lilia M. Babé

Structure-based design of nonpeptide inhibitors specific for the human immunodeficiency virus 1 protease.

Renée L. DesJarlais, George Seibel, Irwin D. Kuntz et al. · Proceedings of the National Academy of Sciences · 1990 · 254 citations · Full text

Crystal Structure, Molecular Biology, Antiviral Drug +18

Defining the level of human immunodeficiency virus type 1 (HIV-1) protease activity required for HIV-1 particle maturation and infectivity

Jacqueline Rose, Lilia M. Babé, Charles S. Craik · Journal of Virology · 1995 · 126 citations · Full text

Viral Replication, Virion Maturation, Immunology +19

Rational Design of a Multiepitope Vaccine Encoding T-Lymphocyte Epitopes for Treatment of Chronic Hepatitis B Virus Infections

Erik Depla, Annegret Van der Aa, Brian Livingston et al. · Journal of Virology · 2007 · 107 citations · Full text

Hla Immunogenetics, Immunology, Hepatitis B +18

Synthetic “interface” peptides alter dimeric assembly of the HIV 1 and 2 proteases

Lilia M. Babé, Jason Rosé, Charles S. Craik · Protein Science · 1992 · 93 citations · Full text

Inhibition of HIV protease activity by heterodimer formation

Lilia M. Babé, Sergio Pîchuantes, Charles S. Craik · Biochemistry · 1991 · 65 citations